Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
- 31 August 1996
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 98 (2) , 274-282
- https://doi.org/10.1016/s0091-6749(96)70150-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal sprayAllergy, 1993
- Once- versus Twice-Daily Fluticasone Propionate Aqueous Nasal Spray for Seasonal Allergic RhinitisAmerican Journal of Rhinology, 1993
- Intranasal Fluticasone PropionateDrugs, 1992
- The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposureJournal of Allergy and Clinical Immunology, 1991
- Eosinophils, secretory responsiveness and glucocorticoid‐induced effects on the nasal mucosa during a weak pollen seasonClinical and Experimental Allergy, 1991
- Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatmentAllergy, 1989
- The cellular response of the human allergic mucosa to natural allergen exposureJournal of Allergy and Clinical Immunology, 1988
- Effect of beclomethasone dipropionate on nasal metachromatic cell sub‐populationsClinical and Experimental Allergy, 1986
- Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosolJournal of Allergy and Clinical Immunology, 1986
- Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjectsJournal of Allergy and Clinical Immunology, 1975